Why the study?
Does intravenous lidocaine prevent ventricular fibrillation in patients with acute myocardial infarction?
Does intravenous lidocaine prevent ventricular fibrillation in patients with acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Discusses the historical context and appropriateness of prophylactic intravenous lidocaine for preventing ventricular fibrillation in acute myocardial infarction.
LIDOCAINE was introduced into medical use at the inception of the era of coronary care units.1 , 2 These units were established to protect patients against lethal ventricular arrhythmias known to occur in the early stages of acute myocardial infarction. Lidocaine administered intravenously abolished the ubiquitous ectopic activity promptly and consistently. The powerful antiarrhythmic drug was believed to contribute substantially to the improved prognoses of patients treated in coronary care units. The absence of convincing data that the drug saved lives did not quench the enthusiasm of coronary care physicians for injecting all comers with lidocaine.The appropriateness of the prophylactic use . . .
No takes yet. Share an insight, caveat, or question.
Bernard Lown (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: